Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
YSX TECH. CO. LTD Announces Unaudited Financial Results for the Six Months Ended September 30, 2024
-
Blockchain is Growing Fast, and Cloud Mining is a Popular Investment - ION Mining Expands Global Operations with High-Yield Contracts
-
Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors
-
Site-Centric Strategies to Fast-Track Study Startup, Upcoming Webinar Hosted by Xtalks
-
Streamlined Accessioning with Comprehensive Labware Labeling, Upcoming Webinar Hosted by Xtalks
-
Gabelli Dividend & Income Trust Trustees Have Approved Spin-Off of Gabelli Preferred Securities Trust Focusing on Preferred Securities
-
Dror Successfully Completes User Experience Trial of its new ZSmile Platform
-
Entera Bio to Participate in Upcoming Events
-
Retrieve Medical Holdings Inc. Announces Letter of Intent to Acquire Cúratus LLC, Strengthening AI-Powered Healthcare Solutions
-
Patrick Industries, Inc. Completes Acquisition of Medallion Instrumentation Systems, LLC
-
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel
-
Nomad Foods to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 3, 2025
-
Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates
-
Universal Display Corporation Announces Participation at Upcoming Conferences
-
Knight Watch Inc. Expands Offices into New Location: Indianapolis, Indiana
-
Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference
-
HYCO1 Celebrates Groundbreaking as Syngas Technology Provider for UBE Corporation's New EV Electrolyte Plant in New Orleans
-
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
-
Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
-
European Medicines Agency Validates Gilead’s Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention
-
DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors
-
Touchstone Investments Debuts Emerging Markets ex-China Growth ETF to Gain Exposure Across Developing Markets
-
Redfin Reports Florida Condo Prices Are Holding Up Best Away From the Coast
-
Workday CEO to Present at the Morgan Stanley Technology, Media & Telecom Conference on March 4, 2025
-
Sonos Announces Participation in Morgan Stanley Technology, Media & Telecom Conference
-
Everbridge Service Agreement Terms Ranked Among the Most Customer-Friendly by TermScout
-
RXO Releases the Q1 Curve Freight Market Forecast
-
Catalyst™ Fence Solutions Debuts Brand and Products at FENCETECH, on New Website
-
OneSubsea and Innovex Sign Master Service Agreement for Subsea Wellhead Technology
-
OSI Systems Receives $32 Million Order to Provide RF-based Critical Communication Systems
-
Canacol Energy Ltd. Provides 2025 Capital and Gas Sales Guidance
-
Eyeon Group AB (publ) Announces Strategic Partnership with Point Wild to Expand Cybersecurity Offerings
-
Signia Introduces Pure Charge&Go BCT IX Hearing Aids Featuring Bluetooth® Classic Connectivity with No Compromise
-
Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital
-
Schrödinger to Participate in Upcoming Investor Conferences
-
Gabelli Dividend & Income Trust Trustees Have Approved Spin-Off of Gabelli Preferred Securities Trust Focusing on Preferred Securities
-
Trump Media, Rumble File Court Motion against Suspension of Rumble in Brazil
-
MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
-
Lead Real Estate Co., Ltd Anticipates Completion of New Condominium, EXCELSIOR NAKAMEGURO, in Tokyo
-
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
-
Blum Holdings, Inc. Announces Final Global Settlement with People’s California, LLC
-
Safety Shot CEO Jarrett Boon and Yerbaé CEO Todd Gibson Join FORCE Family Webinar to Discuss How Safety Shot Plans to Disrupt the Functional Wellness and Beverage Market
-
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
-
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
-
TruGolf Links to Launch Revolutionary Hybrid Golf Concept for Franchisees
-
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
-
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
-
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
-
ReCo Expands Its FinTech Solutions for Municipalities as It Marks Three Years with 100GROUP
-
Foresight Announces the Integration of NVIDIA Jetson Orin into its Perception Technologies
